Developing new strategies for diagnosing and treating kidney diseases
Resource Development Core
['FUNDING_OTHER'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-10915006
This study is working on a new platform to help doctors better diagnose and treat kidney diseases by combining different types of health data, which could lead to new tools and treatments that improve care for patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-10915006 on ClinicalTrials.gov |
What this research studies
This research focuses on creating a comprehensive platform to enhance the diagnosis and treatment of kidney diseases through a systems biology approach. It aims to integrate various types of data, including biological samples and social determinants of health, to identify promising biomarkers and develop effective clinical trial designs. By leveraging existing resources and databases, the project will support the kidney research community in improving patient outcomes. Patients may benefit from new diagnostic tools and treatment strategies that arise from this innovative research.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with acute or chronic kidney diseases who may benefit from novel diagnostic and treatment strategies.
Not a fit: Patients with kidney diseases that are not amenable to new diagnostic or therapeutic strategies may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic and therapeutic options for patients with kidney diseases.
How similar studies have performed: Other research initiatives utilizing systems biology approaches have shown promise in improving patient outcomes in various medical fields, indicating potential success for this novel approach.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HAYEK, SALIM — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: HAYEK, SALIM
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.